NCT00369759

Brief Summary

The primary objective of this study is to describe the incidence of RSV-associated LRI among infants \<1 year of age presenting to the ED during selected shoulder months.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,048

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2006

Geographic Reach
1 country

38 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 24, 2006

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 29, 2006

Completed
3 days until next milestone

Study Start

First participant enrolled

September 1, 2006

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2008

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2008

Completed
Last Updated

March 17, 2009

Status Verified

March 1, 2009

Enrollment Period

1.8 years

First QC Date

August 24, 2006

Last Update Submit

March 16, 2009

Conditions

Keywords

Acute Lower Respiratory InfectionRetractionsBronchiolitis or pneumoniaWheezingRalesCrackles

Outcome Measures

Primary Outcomes (1)

  • Measuring the incidence of RSV-associated, LRI or apnea among infants <1 yr. old presenting the Emergency Dept. during shoulder months.

    July 2008

Secondary Outcomes (4)

  • Clinical outcome of infants at Emergency Dept. with RSV-associated LRI or apnea.(hospital admission, 23 hr.-observations,no. of outpatient and/or urgent care visits,ICU,mechanical ventilation,supplemental oxygen use, meds,admission rate)

    July 2008

  • Societal burden(no. of days lost from work by parent/guardian) for infants through 14 days after index ED visit and through hospital discharge.

    July 2008

  • Comparison of rates of RSV-associated LRI or apnea during the peak periods and between shoulder and peak periods.

    July 2008

  • Overall rates of RSV-associated LRI or apnea based on general ED statistics collected during the entire study period, including outside recruitment periods.

    July 2008

Study Arms (3)

1

Bronchiolitis, pneumonia or Lower Respiratory Infection or LRI (Season 1: 2006-'07 and same for Season 2: 2007 - '08)

Other: Emergency Dept. Subjects with LRI or Apnea

2

Bronchiolitis, pneumonia or Lower Respiratory Infection or LRI (Season 1: 2006-'07 and same for Season 2: 2007 - '08)

Other: Emergency Dept. Subjects with LRI or Apnea

3

Bronchiolitis, pneumonia or Lower Respiratory Infection or LRI (Season 1: 2006-'07 and same for Season 2: 2007 - '08)

Other: Emergency Dept. Subjects with LRI or Apnea

Interventions

No intervention; Epidemiological Study

123

Eligibility Criteria

Age1 Day - 12 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Eligible subjects with RSV results.

You may qualify if:

  • Written informed consent from parent/guardian to participate in this study
  • Male and female infants \<1 year of age (child must be entered before his/her 1st birthday)
  • Physician diagnosis of either a) acute LRI or b) apnea below:
  • A) Acute LRI, defined as:
  • Medical diagnosis of bronchiolitis or pneumonia, or
  • In the absence of either of these diagnoses, LRI will be determined by the investigator after review of the medical record and must include at least one of the following:
  • Retractions
  • Wheezing
  • Rales or crackles
  • The presence of a new infiltrate, if a chest X-ray is available, which must be diagnosed by the ED physician or radiologist
  • B) Apnea, defined as either:
  • Cessation of breathing for \>20 seconds by history or observation, or
  • Cessation of breathing for any length of time if accompanied by cyanosis or pallor, bradycardia as detected by a monitor, or
  • ED primary diagnosis of apnea
  • Parent/guardian has the ability and willingness to be available for a follow-up interview by telephone

You may not qualify if:

  • Use of palivizumab or RSV-IGIV at any time prior to enrollment
  • Participation in trials of investigational RSV prophylaxis or therapeutic agents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (38)

Maricopa Medical Center

Phoenix, Arizona, 85008, United States

Location

Olive View- UCLA Medical Center

Sylmar, California, 91342, United States

Location

The Children's Hospital

Denver, Colorado, 80218, United States

Location

Alfred I. duPont Hospital for Children

Wilmington, Delaware, 19803-3607, United States

Location

Alfred J. Dupont Hospital for Children

Wilmington, Delaware, 19803-3607, United States

Location

Children's National Medical Center

Washington D.C., District of Columbia, 20010-2970, United States

Location

Batchelor Children's Institute

Miami, Florida, 33136, United States

Location

Miami Children's Hospital Research Institute

Miami, Florida, 33155, United States

Location

Emory University

Atlanta, Georgia, 30329, United States

Location

Children's Healthcare of Atlanta

Atlanta, Georgia, 30342, United States

Location

Children's Memorial Hospital

Chicago, Illinois, 60614, United States

Location

University of Kentucky Chandler Medical Center/University of Kentucky Clinical Research

Lexington, Kentucky, 40536-0298, United States

Location

Louisiana State University Health Sciences Center

Shreveport, Louisiana, 71130, United States

Location

Children's National Medical Center

Baltimore, Maryland, 21201, United States

Location

University of Maryland

Baltimore, Maryland, 21201, United States

Location

Children's Hospital of Michigan

Detroit, Michigan, 48201, United States

Location

Hurley Medical Center

Flint, Michigan, 48503, United States

Location

University of Mississippi

Jackson, Mississippi, 39216, United States

Location

St. Louis Children's Hospital (Washington University)

St Louis, Missouri, 63110, United States

Location

University of Nebraska Medical Center combined Divistion of Pediatric Infectious Disease

Omaha, Nebraska, 68178, United States

Location

Children's Hospital of Buffalo

Buffalo, New York, 14222, United States

Location

Upstate Medical University

Syracuse, New York, 13202, United States

Location

Wake Forest University Medical Center

Winston-Salem, North Carolina, 27157, United States

Location

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, 45229, United States

Location

Case Western Reserve University

Cleveland, Ohio, 44106, United States

Location

Columbus Children's Hospital - Nationwide Children's of Colombus

Columbus, Ohio, 43205, United States

Location

The Children's Medical Center of Dayton

Dayton, Ohio, 45404, United States

Location

Doernbecher Children's Hospital Oregon Health Sciences University Hospital

Portland, Oregon, 97239, United States

Location

Temple University Children's Medical Center

Philadelphia, Pennsylvania, 19140, United States

Location

Medical University of SC

Charleston, South Carolina, 29425, United States

Location

University of Tennesee, LeBonheur Children's Med. Center

Memphis, Tennessee, 38103, United States

Location

Driscoll Children's Hospital

Corpus Christi, Texas, 78411, United States

Location

University of Texas Southwestern Medical Center

Dallas, Texas, 75390-9063, United States

Location

University of Texas, Southwestern Medical Center

Dallas, Texas, 75390, United States

Location

Austin Children's Hospital

Temple, Texas, 76502, United States

Location

Seattle Children's Hospital and Regional Medical Center

Seattle, Washington, 98105-0371, United States

Location

Medical College of Wisconsin

Milwaukee, Wisconsin, 53226, United States

Location

Medical College of Wisconsin

Milwaukee, Wisconsin, 53326, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Nasal wash specimen (RSV)

MeSH Terms

Conditions

Respiratory Tract InfectionsBronchiolitisPneumoniaApneaRespiratory Sounds

Condition Hierarchy (Ancestors)

InfectionsRespiratory Tract DiseasesBronchitisBronchial DiseasesLung Diseases, ObstructiveLung DiseasesRespiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jessie R. Groothuis, M.D.

    MedImmune LLC

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

August 24, 2006

First Posted

August 29, 2006

Study Start

September 1, 2006

Primary Completion

July 1, 2008

Study Completion

September 1, 2008

Last Updated

March 17, 2009

Record last verified: 2009-03

Locations